Le Lézard
Classified in: Health
Subject: FDA

Q'Apel Medical Announces FDA Clearance for Walrus Balloon Guide Catheter


FREMONT, Calif., July 17, 2019 /PRNewswire/ -- Q'Apel Medical announced today that it received U.S. Food and Drug Administration clearance for its novel walrus Balloon Guide Catheter (BGC). 

Logo

In the neurovascular space where speed, reliability and performance are so critical to patient outcomes, physicians and patients demand that innovative technologies are best-in-class. The walrus BGC, with its 087 ID, marks a big step forward in balloon guide catheter technology and for stroke patients worldwide. 

"Catheter compatibility in the neurovascular space is critical to the treatment of stroke patients. Until now, widespread adoption of BGCs has been limited due to technical constraints. The walrus BGC was specifically designed to address these technical shortcomings with an 087 ID in a highly trackable catheter platform," said Raymond Turner MD, professor of neurosurgery at Prisma Health. "I expect its introduction will be welcomed by neurovascular physicians everywhere." 

The walrus BGC represents the second FDA-cleared technology from Q'Apel in the past 12 months, joining the wahoo Access Catheter with Selectflex technology in Q'Apel's expanding product portfolio. Q'Apel has several more innovative products slated to come to market over the course of the next year. 

About Q'Apel Medical LLC

Q'Apel Medical LLC is a medical device company founded with the sole purpose of developing best-in-class technology for neurovascular interventions. Learn more about Q'Apel at www.option3llc.com/portfolio.

For more information about Q'Apel and the walrus BGC, please email info@option3llc.com.

Related Images

qapel-medical.jpg

SOURCE Q'Apel Medical


These press releases may also interest you

at 11:52
As the city of Toronto joins a large majority of the province with entering stage three of the Ontario government's reopening plan, and with treatment plans still far from being perfected, preventive methods and detections ? in addition to social...

at 11:45
"CBS This Morning" Co-Host Gayle King will moderate an online panel discussion about the Trauma of Incarceration that Venice Family Clinic is hosting at 11 a.m. Friday, August 14, with Susan Burton, who founded A New Way of Life Reentry Project to...

at 11:44
Dr. LaVern McCants, a fearless author with a doctorate in education, parent advocate, School Improvement Consultant, motivational speaker, and former educator, stated that "it is remarkable that many schools are choosing to provide remote learning;...

at 11:40
BIOQUAL announces the publication of the successful testing of an mRNA vaccine in non-human primates. The candidate vaccine, mRNA-1273, was co-developed by scientists at the NIAID Vaccine Research Center and a pharmaceutical company. The animal...

at 11:20
IM HealthScience®, innovators of medical foods and dietary supplements, today announced the results of a high-quality, nationwide survey conducted among a representative and projectable sample of U.S. gastroenterologists, which again confirmed...

at 11:15
Calls for insurance carrier incentives, training to allow physicians' staffs to provide resources on lower-cost/high-value providers. Consumers in just one Massachusetts county could have saved nearly $22 million in a single year and $116.6 million...



News published on 17 july 2019 at 00:39 and distributed by: